GlassScriptPhysician profile
Robert B Wyko
NPI 1891730685
$3,787.95
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,287 · 2020: $391 · 2021: $1,082 · 2022: $361 · 2023: $490 · 2024: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $923.79 | 2019-2023 | Breztri |
| Abbvie INC. | $913.72 | 2021-2024 | Vraylar, Qulipta, Ubrelvy |
| Allergan, INC. | $437.33 | 2019-2020 | |
| Pfizer INC. | $311.23 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $258.38 | 2021-2022 | |
| Novo Nordisk INC | $150.21 | 2019-2024 | Ozempic, Rybelsus |
| Astellas Pharma US INC | $138.34 | 2019 | |
| Stryker Corporation | $131.26 | 2023 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed |
| Amgen INC. | $110.24 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $90.32 | 2019-2020 | |
| Glaxosmithkline, LLC. | $88.45 | 2019-2023 | Trelegy Ellipta |
| Lilly USA, LLC | $74.20 | 2019-2020 | |
| Bolton Medical INC | $52.44 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $27.11 | 2019 | |
| Supernus Pharmaceuticals, INC. | $26.72 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $15.84 | 2019 | |
| Horizon Therapeutics Plc | $15.71 | 2021 | |
| Exact Sciences Corporation | $15.50 | 2024 | Cologuard Collection Kit |
| Romark Laboratories, Lc | $7.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wyko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.